Show simple item record

dc.contributor.authorOezkaya, Esen
dc.date.accessioned2021-03-05T12:01:53Z
dc.date.available2021-03-05T12:01:53Z
dc.date.issued2008
dc.identifier.citationOezkaya E., "Fixed drug eruption: state of the art", JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, cilt.6, ss.181-188, 2008
dc.identifier.issn1610-0379
dc.identifier.otherav_ab102fc8-5bd1-4fe1-b9ff-0c7b7dcec4dd
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/114232
dc.identifier.urihttps://doi.org/10.1111/j.1610-0387.2007.06491.x
dc.description.abstractFixed drug eruption (FIDE) is a common type of cutaneous adverse drug reaction. There may be a genetic background as significant associations have been identified between HLA types and specific FDE. Systemic provocation is still the gold standard for establishing the offending agent in FIDE, but topical provocation testing offers a promising alternative approach. A standardized method does not exist, and the approach must likely be varied for different agents. The mystery of site preference in FIDE is still unresolved. Possible explanations include properties of the drug, trauma and viscerocutaneous reflex patterns.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectDermatoloji
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectDERMATOLOJİ
dc.titleFixed drug eruption: state of the art
dc.typeMakale
dc.relation.journalJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri
dc.identifier.volume6
dc.identifier.issue3
dc.identifier.startpage181
dc.identifier.endpage188
dc.contributor.firstauthorID54972


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record